No Data
No Data
Express News | CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Canaccord Genuity Maintains Buy on CervoMed, Lowers Price Target to $12
Roth MKM Maintains CervoMed(CRVO.US) With Buy Rating, Cuts Target Price to $4
A Quick Look at Today's Ratings for CervoMed(CRVO.US), With a Forecast Between $12 to $12
Chardan Capital Downgrades CervoMed to Neutral
No Data
Nyx : Don't know about new highs but I guarantee if I bought the stock it's going to fall for over a week straight. This is the 5th time already my business sense is . Bought at 2.55 I'll just take the loss.